Synthesis and biological activity of N-substituted tetrahydro-γ-carbolins bearing bis(dimethylamino)phenothiazine moiety
- 1 March 2015
- journal article
- Published by Springer Nature in Russian Chemical Bulletin
- Vol. 64 (3) , 718-722
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Modification of biologically active amides and amines with the fluorine-containing heterocycles 9. γ-Carbolines modified by the 2-trifluoromethylimidazo-[1,2-a]pyridin-6-yl fragmentRussian Chemical Bulletin, 2013
- Chronic Administration of Dimebon Ameliorates Pathology in Tau P301S Transgenic MiceJournal of Alzheimer’s Disease, 2013
- New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugsBritish Journal of Clinical Pharmacology, 2012
- Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Diseases as Disease Modifying AgentsExperimental Neurobiology, 2010
- Hindering of proteinopathy-induced neurodegeneration as a new mechanism of action for neuroprotectors and cognition enhancing compoundsDoklady Biochemistry and Biophysics, 2009
- Methylene blue and dimebon inhibit aggregation of TDP‐43 in cellular modelsFEBS Letters, 2009
- Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled studyThe Lancet, 2008
- Comparative Study of Action Mechanisms of Dimebon and Memantine on AMPA- and NMDA-Subtypes Glutamate Receptors in Rat Cerebral NeuronsBulletin of Experimental Biology and Medicine, 2003
- Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical dataNeuropharmacology, 1999
- The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 1999